Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ADC Therapeutics (ADCT) Return on Equity (2023 - 2026)

ADC Therapeutics has reported Return on Equity over the past 4 years, most recently at 0.01% for Q1 2026.

  • Quarterly results put Return on Equity at 0.01% for Q1 2026, changed 0.0% from a year ago — trailing twelve months through Mar 2026 was 0.01% (changed 0.0% YoY), and the annual figure for FY2021 was 0.01%, changed 0.0%.
  • Return on Equity reached 0.01% in Q1 2026 per ADCT's latest filing, up from 0.01% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.04% in Q3 2023 and bottomed at 0.37% in Q2 2023.
  • Median Return on Equity over the past 4 years was 0.01% (2026), compared with a mean of 0.03%.
  • Peak annual rise in Return on Equity hit 37bps in 2024, while the deepest fall reached -3bps in 2024.
  • Over 4 years, Return on Equity stood at 0.01% in 2023, then plummeted by -54bps to 0.01% in 2024, then dropped by -4bps to 0.01% in 2025, then increased by 1bps to 0.01% in 2026.
  • Business Quant data shows Return on Equity for ADCT at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.